Biol specimens for lenacapavir PEP

Active Definitive Contract Awarded

Contract number
75D30126C21592
Awardee
Awarding agency
Obligated
$350,000

Award facts

Contract value 100% obligated
$350,000.00 Current and potential, with all options
Completion date 3% complete
Current and potential, with all options
NAICS code
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC
AN12 Health R&D Services; Health Care Services; Applied Research
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Atlanta, GA 30329, USA

Award details come from SAM.gov/FPDS.

About this award

CDC Pittsburgh awarded a $350,000 definitive contract to Emory University for biological specimens for lenacapavir PEP on September 23, 2026, under firm fixed-price terms with no set-aside.

Place of performance is Atlanta, GA. The contract runs through September 21, 2028. Emory University, a tax-exempt non-profit educational institution headquartered in Atlanta, operates as a prime recipient on the majority of its federal awards, with a portfolio concentrated in biomedical research and health services delivery across NIH, CDC, and NCI funding streams.

Quick answers

Who was awarded contract 75D30126C21592?

75D30126C21592 was awarded to Emory University by CDC Pittsburgh (Centers for Disease Control and Prevention) on September 23, 2026.

How much is contract 75D30126C21592 worth?

The government has obligated $350,000 on 75D30126C21592.

Was contract 75D30126C21592 competed?

The extent of competition for 75D30126C21592 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award